<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cardiovascular gender differences &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/cardiovascular-gender-differences/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 17 Oct 2025 15:55:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Cardiovascular gender differences &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Beta-2 Glycoprotein I: New Regulator of HDL in Women</title>
		<link>https://bioengineer.org/beta-2-glycoprotein-i-new-regulator-of-hdl-in-women/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 17 Oct 2025 15:55:10 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[Apolipoprotein E]]></category>
		<category><![CDATA[Beta-2 glycoprotein I]]></category>
		<category><![CDATA[Cardiovascular gender differences]]></category>
		<category><![CDATA[HDL regulation in women]]></category>
		<category><![CDATA[Personalized medicine for women]]></category>
		<guid isPermaLink="false">https://bioengineer.org/beta-2-glycoprotein-i-new-regulator-of-hdl-in-women/</guid>

					<description><![CDATA[In a groundbreaking revelation within the field of lipid metabolism and cardiovascular health, researchers have identified a novel role for beta-2 glycoprotein I (β2GPI) as a regulator of apolipoprotein E (ApoE)-containing high-density lipoprotein (HDL) particles, primarily in females. This discovery has far-reaching implications not only for understanding lipid profiles but also for tailoring personalized medicine [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">282901</post-id>	</item>
	</channel>
</rss>
